Literature DB >> 11578016

Bone mineral density in women and men with early rheumatoid arthritis.

C Keller1, I Hafström, B Svensson.   

Abstract

OBJECTIVE: To study bone mineral density (BMD) in patients with early rheumatoid arthritis.
METHODS: Dual x-ray absorptiometry was performed in 227 patients, 149 women and 78 men, with rheumatoid arthritis (RA) of no more than 12 months duration.
RESULTS: Women, as well as men above 60 years of age, had a BMD at spine and hip comparable with age and sex matched reference populations. Men younger than 60 years had a tendency to lower BMD. Although the proportion of female patients with osteoporosis was not higher than in the reference, population the proportion of patients with reduced bone mass was increased, and this was found also in men. There was no significant association between BMD and disease duration, disease activity or disability.
CONCLUSION: Untreated patients with early RA have a BMD in spine and hip not significantly different from that of normal reference populations. However, an increased number of the patients had reduced bone mass already at disease onset.

Entities:  

Mesh:

Year:  2001        PMID: 11578016     DOI: 10.1080/030097401316909558

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  11 in total

1.  Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.

Authors:  B-M Nyhäll-Wåhlin; L T H Jacobsson; I F Petersson; C Turesson
Journal:  Ann Rheum Dis       Date:  2005-09-15       Impact factor: 19.103

2.  Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis.

Authors:  Hanh-Hung Dao; Quan-Trung Do; Junichi Sakamoto
Journal:  Clin Rheumatol       Date:  2011-05-06       Impact factor: 2.980

3.  Bone mineral density in patients with Behçet's disease.

Authors:  Ali Bicer; Umit Tursen; Tamer Irfan Kaya; Caner Ozer; Handan Camdeviren; Guliz Ikizoglu; Canan Erdogan
Journal:  Rheumatol Int       Date:  2003-10-11       Impact factor: 2.631

Review 4.  [Bone densitometry in inflammatory rheumatic diseases : Characteristics of the measurement site and disease-specific factors].

Authors:  H Franck; J Braun; F Buttgereit; W Demary; G Hein; J Kekow; G Schett; P M Kern
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

5.  Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis.

Authors:  M Güler-Yüksel; J Bijsterbosch; Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; H K Ronday; A J Peeters; J M de Jonge-Bok; F C Breedveld; B A C Dijkmans; C F Allaart; W F Lems
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

6.  The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis.

Authors:  Funda Tascioglu; Cengiz Oner; Onur Armagan
Journal:  Rheumatol Int       Date:  2003-03-21       Impact factor: 2.631

7.  Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

Authors:  M C van der Goes; J W G Jacobs; M S Jurgens; M F Bakker; M J van der Veen; J H van der Werf; P M J Welsing; J W J Bijlsma
Journal:  Osteoporos Int       Date:  2012-08-02       Impact factor: 4.507

Review 8.  The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects.

Authors:  Marlies C van der Goes; Johannes W Jacobs; Johannes W Bijlsma
Journal:  Arthritis Res Ther       Date:  2014-11-13       Impact factor: 5.156

9.  Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort.

Authors:  Ingiäld Hafström; Sofia Ajeganova; Kristina Forslind; Björn Svensson
Journal:  Arthritis Res Ther       Date:  2019-02-04       Impact factor: 5.156

10.  Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.

Authors:  Serena Bugatti; Laura Bogliolo; Barbara Vitolo; Antonio Manzo; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.